![David Burke](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Burke
Investor Relations Kontakt bei
SERNOVA BIOTHERAPEUTICS INC
Profil
David Burke currently works at The Ruth Group, Inc., as Vice President, The IGB Group, as Vice President, and Sernova Biotherapeutics, Inc., as Vice President-Investor Relations from 2024.
Mr. Burke also formerly worked at Albemarle Corp., as Director-Investor Relations from 2021 to 2022, Rigel Pharmaceuticals, Inc., as Director-Investor Relations & Communications from 2018 to 2021, Dynavax Technologies Corp., as Director-IR & Corporate Communications from 2018 to 2019, and Aldeyra Therapeutics, Inc., as Head-Investor Relations.
Mr. Burke received his undergraduate degree from the University of North Carolina at Chapel Hill.
Aktive Positionen von David Burke
| Unternehmen | Position | Beginn |
|---|---|---|
| SERNOVA BIOTHERAPEUTICS INC | Investor Relations Kontakt | 11.10.2024 |
The IGB Group
 The IGB Group Miscellaneous Commercial ServicesCommercial Services Operates as an independent investor relations, advisory and strategic communications firm | Präsident | - |
The Ruth Group, Inc.
 The Ruth Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides investor and public relations services | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von David Burke
| Unternehmen | Position | Ende |
|---|---|---|
| ALBEMARLE CORPORATION | Investor Relations Kontakt | 01.05.2022 |
| RIGEL PHARMACEUTICALS, INC. | Investor Relations Kontakt | 01.01.2021 |
| DYNAVAX TECHNOLOGIES CORPORATION | Investor Relations Kontakt | 29.01.2019 |
| ALDEYRA THERAPEUTICS, INC. | Investor Relations Kontakt | - |
Ausbildung von David Burke
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
23
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Albemarle Corp.
 Albemarle Corp. Chemicals: SpecialtyProcess Industries Manufactures basic lithium compounds for energy storage, plastic materials and organometallic co-catalysts | Process Industries |
Rigel Pharmaceuticals, Inc.
 Rigel Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which discovers, develops and provides novel small-molecule drugs | Health Technology |
Dynavax Technologies Corp.
 Dynavax Technologies Corp. BiotechnologyHealth Technology Develops and commercializes novel products to prevent and treat infectious diseases | Health Technology |
Sernova Biotherapeutics, Inc.
 Sernova Biotherapeutics, Inc. BiotechnologyHealth Technology Develops life science products | Health Technology |
Aldeyra Therapeutics, Inc.
 Aldeyra Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for eye diseases | Health Technology |
The Ruth Group, Inc.
The Ruth Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides investor and public relations services | Commercial Services |
The IGB Group
The IGB Group Miscellaneous Commercial ServicesCommercial Services Operates as an independent investor relations, advisory and strategic communications firm | Commercial Services |
University of North Carolina at Chapel Hill
 University of North Carolina at Chapel Hill Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
